US Patent Issued to Emory University, Children's Healthcare of Atlanta on Nov. 11 for "Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, pharmaceutical compositions, and uses thereof" (Georgia Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,595, issued on Nov. 11, was assigned to Emory University (Atlanta) and Children's Healthcare of Atlanta Inc. (Atlanta).

"Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, pharmaceutical compositions, and uses thereof" was invented by Eric Sorscher (Atlanta), Haian Fu (Decatur, Ga.), Huw Davies (Suwanee, Ga.), Jeong Hong (Decatur, Ga.), Yuhong Du (Atlanta), Andras Rab (Atlanta), Candela Manfredi (Atlanta), Xun Yang (Atlanta) and Zhi Ren (Atlanta).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to compounds that are cystic fibrosis transmembrane conductance regulator (CFTR) modulators and pharmaceutical compo...